Page last updated: 2024-11-05

2,4-thiazolidinedione and Diabetes, Gestational

2,4-thiazolidinedione has been researched along with Diabetes, Gestational in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pajvani, UB1
Hawkins, M1
Combs, TP1
Rajala, MW1
Doebber, T1
Berger, JP1
Wagner, JA1
Wu, M1
Knopps, A1
Xiang, AH1
Utzschneider, KM1
Kahn, SE1
Olefsky, JM1
Buchanan, TA1
Scherer, PE1

Other Studies

1 other study available for 2,4-thiazolidinedione and Diabetes, Gestational

ArticleYear
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.
    The Journal of biological chemistry, 2004, Mar-26, Volume: 279, Issue:13

    Topics: 3T3-L1 Cells; Adiponectin; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blood Glucose; Chrom

2004